Skip to content
PeptideHormone

Tirzepatide vs Brenipatide

A dual GIP and GLP-1 receptor agonist — the first of the co-agonists. A long-acting dual GIP/GLP-1 agonist aimed at the brain's reward circuitry rather than the scale. Side by side: type, evidence tier, receptor, molecular weight, and half-life — the same fields as each monograph, rearranged so the engineering difference is visible.

Tirzepatide
Brenipatide
LY3537031
Also known asMounjaro, Zepbound—
TypeAnalogAnalog
EvidenceEstablishedInvestigational
FamilyIncretins & metabolicIncretins & metabolic
ClassDual GIP/GLP-1 receptor agonist (39 aa, acylated)GIP/GLP-1 dual agonist (acylated peptide)
Receptor / targetGIP receptor + GLP-1 receptorGIP + GLP-1 receptors
Molecular weight~4,813.5 Da≈4,900 Da
Half-life
~5 days (~120 h)
Model dosing
engineered for an extended dosing interval (not yet disclosed)
Based onGlucose-dependent insulinotropic polypeptideGlucagon-like peptide-1

Half-life bars are on a logarithmic scale across the molecules shown. Reference values for the native or representative form — educational only, not medical or dosing advice.

Common questions

What is the difference between Tirzepatide and Brenipatide?
Tirzepatide is an engineered analog based on Glucose-dependent insulinotropic polypeptide; Brenipatide is an engineered analog based on Glucagon-like peptide-1. Tirzepatide signals at GIP receptor + GLP-1 receptor; Brenipatide signals at GIP + GLP-1 receptors.
How do the half-lives of Tirzepatide and LY3537031 compare?
The reported circulating half-life of Tirzepatide is ~5 days (~120 h); Brenipatide is engineered for an extended dosing interval (not yet disclosed). These are reference values for the native or representative form — educational only, not dosing advice.
Is Tirzepatide the same as Mounjaro?
Mounjaro, Zepbound are brand names of Tirzepatide. This comparison describes the molecules, not branded products.

Prefer the other order? Brenipatide vs Tirzepatide. Or open the interactive comparison tool to add more molecules.